WO2012120176A3 - Proteínas recombinantes con efecto antitumoral - Google Patents
Proteínas recombinantes con efecto antitumoral Download PDFInfo
- Publication number
- WO2012120176A3 WO2012120176A3 PCT/ES2012/070150 ES2012070150W WO2012120176A3 WO 2012120176 A3 WO2012120176 A3 WO 2012120176A3 ES 2012070150 W ES2012070150 W ES 2012070150W WO 2012120176 A3 WO2012120176 A3 WO 2012120176A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recombinant proteins
- antitumor effects
- vector
- sequence
- relates
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 3
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 abstract 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 102000006382 Ribonucleases Human genes 0.000 abstract 1
- 108010083644 Ribonucleases Proteins 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000030648 nucleus localization Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27005—Pancreatic ribonuclease (3.1.27.5)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención proporciona una proteína recombinante con actividad ribonucleasa que comprende una secuencia derivada de la ribonucleasa pancreática humana (RNasa-PH) de secuencia SEC ID NO: 37 fusionada a través de su extremo N-terminal a una secuencia de localización nuclear convencional, así como una molécula de ADN recombinante que codifica para esta proteína, un vector que comprende dicha molécula de ADN y una célula que comprende dicho vector. Adicionalmente la presente invención está referida a un procedimiento para la obtención de la proteína recombinante y el uso de la misma como agente antitumoral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP201130324 | 2011-03-10 | ||
ES201130324A ES2388020B1 (es) | 2011-03-10 | 2011-03-10 | Proteínas recombinantes con efecto antitumoral. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012120176A2 WO2012120176A2 (es) | 2012-09-13 |
WO2012120176A3 true WO2012120176A3 (es) | 2012-11-01 |
Family
ID=46798596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2012/070150 WO2012120176A2 (es) | 2011-03-10 | 2012-03-08 | Proteínas recombinantes con efecto antitumoral |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2388020B1 (es) |
WO (1) | WO2012120176A2 (es) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004284977A (ja) * | 2003-03-20 | 2004-10-14 | Masakazu Ueda | ヒト生理活性物質とヒト蛋白質合成阻害物質との挿入融合体 |
US20050261232A1 (en) * | 2004-04-13 | 2005-11-24 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
WO2006138558A2 (en) * | 2005-06-16 | 2006-12-28 | Wisconsin Alumni Research Foundation | Cytotoxic ribonuclease variants |
JP2010180174A (ja) * | 2009-02-06 | 2010-08-19 | Tokyo Univ Of Science | 膵癌の診断方法および膵癌の診断用キット |
WO2011161260A1 (en) * | 2010-06-25 | 2011-12-29 | Adamed Sp. Z O.O. | Anticancer fusion protein |
-
2011
- 2011-03-10 ES ES201130324A patent/ES2388020B1/es active Active
-
2012
- 2012-03-08 WO PCT/ES2012/070150 patent/WO2012120176A2/es active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004284977A (ja) * | 2003-03-20 | 2004-10-14 | Masakazu Ueda | ヒト生理活性物質とヒト蛋白質合成阻害物質との挿入融合体 |
US20050261232A1 (en) * | 2004-04-13 | 2005-11-24 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
WO2006138558A2 (en) * | 2005-06-16 | 2006-12-28 | Wisconsin Alumni Research Foundation | Cytotoxic ribonuclease variants |
JP2010180174A (ja) * | 2009-02-06 | 2010-08-19 | Tokyo Univ Of Science | 膵癌の診断方法および膵癌の診断用キット |
WO2011161260A1 (en) * | 2010-06-25 | 2011-12-29 | Adamed Sp. Z O.O. | Anticancer fusion protein |
Non-Patent Citations (5)
Title |
---|
DATABASE 0 "Human pancreas ribonucleasel (RNasel) sequence, SEQ ID I", accession no. YG98365 * |
DATABASE 0 "Human pancreatic ribonucleasel (RNase 1) chain X , SEQ ID 2", accession no. ZS55938 * |
DATABASE 0 "Human RNase 1 protein SEQID N° 4", accession no. DS52279 * |
DATABASE ACCESSIONNUMBER accession no. EE02927 * |
PERE TUBERT ET AL.: "The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity. Investigational New Drugs", THE JOURNAL OF NEW ANTICANCER AGENTS., vol. 29, no. 5, October 2011 (2011-10-01), pages 811 - 817 * |
Also Published As
Publication number | Publication date |
---|---|
ES2388020B1 (es) | 2013-10-01 |
ES2388020A1 (es) | 2012-10-05 |
WO2012120176A2 (es) | 2012-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013151672A3 (en) | Modified polynucleotides for the production of oncology-related proteins and peptides | |
WO2013055888A3 (en) | Recombinant human naglu protein and uses thereof | |
MX348071B (es) | Variantes de fc. | |
NZ705370A (en) | Fcγriib-specific fc region variant | |
WO2013184939A3 (en) | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide | |
WO2013075066A3 (en) | Variant serum albumin with improved half -life and other properties | |
MX356517B (es) | Polipéptidos de fusión de serpina y métodos de uso de los mismos. | |
MX366103B (es) | Polipeptidos que contienen fc con glicosilacion alterada y funcion efectora reducida. | |
MX2014004214A (es) | Moleculas de acido ribonucleico policistronicas auto-replicantes recombinantes. | |
MX353710B (es) | Polipeptidos que tienen actividad de lisozima y polinucleotidos que los codifican. | |
EP4223772A3 (en) | Optimized factor viii gene | |
NZ742660A (en) | Variants of chymosin with improved milk-clotting properties | |
WO2012160563A3 (en) | Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same | |
WO2012135177A3 (en) | Methods and compositions for cytomegalovirus il-10 protein | |
MX2015003310A (es) | Moleculas de union il-17a novedosas y usos medicos de las mismas. | |
WO2012054929A3 (en) | Use of human serum albumin to decrease antigenicity of therapeutic proteins | |
NZ713602A (en) | Method for refining protein including self-cutting cassette and use thereof | |
IN2015DN03206A (es) | ||
MX349517B (es) | Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos. | |
MX2017007105A (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
NZ760789A (en) | Uti fusion proteins | |
MX350391B (es) | Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican. | |
WO2012122378A3 (en) | Antibody-like proteins for therapeutic and diagnostic use | |
MX2014011890A (es) | Secuencias de acidos nucleicos y peptidos/proteinas de la familia de ft que proporcionan propiedades represoras de la floracion en plantas de tabaco y en plantas transgenicas transformadas con las mismas. | |
WO2012173344A3 (ko) | Csp-b 5'-sar 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12755442 Country of ref document: EP Kind code of ref document: A2 |